Algeria Launches Production of Biometric Chips for Cancer Detection

Cancer diagnosis has been significantly enhanced by recent technological advancements in nanoscience and material design. Cancer chips, a promising outcome of these advances, have great potential in improving clinical outcomes for patients and effectively reducing mortality rates associated with the disease.
Sputnik
Biotechnology research center in the Algeria's city of Constantine has launched production of biometric chips for cancer detection, the advisor to the country's Ministry of Higher Education and Scientific Research, Abdeldjabar Daoudi said.
New Way of Treatment Offers Hope for Pancreatic Cancer Patients
Algerian laboratories are the first in Africa in this field, according to the advisor. The center is one of the 90 laboratories in the world that master this type of medical technology, Daoudi noted.
Previously, similar chips were imported at a unit cost of up to 500 euros.
Cancer chips exhibit promising potential for enhancing clinical outcomes and effectively decreasing mortality rates linked to this disease.